Tag: particulates

How QA Investigates Repeated Aggregation and Fragmentation Failures in Pharma Understanding QA’s Role in Addressing Aggregation and Fragmentation Failures in Pharmaceuticals The pharmaceutical industry faces numerous challenges in ensuring the stability and efficacy of biologic products. Among these challenges, aggregation…

Aggregation and Fragmentation in Regulatory Filing: What Must Be Justified? Understanding the Importance of Aggregation and Fragmentation in Pharmaceutical Regulatory Filing In the realm of pharmaceuticals, especially within the field of biologics, the terms aggregation and fragmentation hold significant importance.…

How Storage and Transport Affect Aggregation and Fragmentation in Pharma Understanding the Impact of Storage and Transport on Aggregation and Fragmentation in Pharma The integrity of biologic products is crucial for their efficacy and safety, making the study of aggregation…

Aggregation and Fragmentation During Manufacturing: What Teams Must Watch Understanding Aggregation and Fragmentation in Biologics Manufacturing The manufacturing of biologics and complex pharmaceutical products presents unique challenges, particularly in terms of protein stability and integrity. Two critical phenomena in this…

How Formulation and Buffer Systems Affect Aggregation and Fragmentation The Impact of Formulation and Buffer Systems on Aggregation and Fragmentation in Biologics Aggregation and fragmentation in pharma are critical phenomena that can significantly affect the efficacy, safety, and stability of…

Aggregation and Fragmentation Testing in Pharma: What Teams Must Know Understanding Aggregation and Fragmentation in Pharmaceutical Development In the realm of pharmaceuticals, particularly in the development and manufacturing of biologics and complex products, the phenomena of aggregation and fragmentation are…

How QA and QC Evaluate Aggregation and Fragmentation in Biologic Products Evaluating Aggregation and Fragmentation in Biologic Products: Insights for QA and QC In the production of biologic products, ensuring the stability and efficacy of proteins and other macromolecules is…

Interview Questions on Aggregation and Fragmentation in Pharma Key Interview Questions on Aggregation and Fragmentation in Pharma The pharmaceutical landscape has evolved significantly with the introduction of biologics and complex products. A critical area of focus in the development and…

Common Causes of Fragmentation in Protein Products and How to Control Them Understanding Fragmentation in Protein Products and Effective Control Strategies Fragmentation and aggregation are significant concerns in the development and manufacturing of biologics and complex products. They can adversely…

Common Causes of Aggregation in Biologics and How to Prevent Them Understanding the Causes of Aggregation in Biologics and Prevention Strategies In the realm of pharmaceuticals, particularly in the development and manufacturing of biologics, the issues of aggregation and fragmentation…